NEW YORK, March 24, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro&nb

SAN FRANCISCO, March 24, 2020 /PRNewswire/ -- IndieBio, the world's most active investor in early stage life science startups, announces an immediate call for COVID-19 related applications. Up to 8 startups will receive a minimum of $250,000 each to pursue the development of diagnostics, therapeutics, vaccines, disinfection, and other soluti

- Curaleaf receives Essential Service Designation in key markets where it has medical dispensaries- To help service the needs of its patients and customers, Company also announces that it will be hiring across its retail, cultivation and processing facilities WAKEFIELD, Mass., March 24, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc.

BRANFORD, Conn. and SEATTLE, March 24, 2020 /PRNewswire/ -- IsoPlexis, the leader in functional cellular proteomics, and the Institute for Systems Biology (ISB) announced a partnership mapping functional immune responses at the single cell level to study COVID-19.

SCHLIEREN, Switzerland, March 24, 2020 /PRNewswire/ -- InSphero AG, the pioneer of 3D cell-based assay technology, today announced that it will offer free safety testing for exploratory COVID-19 medi

DUBLIN and TAMPA, Florida, March 24, 2020 /PRNewswire/ -- Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products. 

SAN FRANCISCO, March 24, 2020 /PRNewswire/ -- Wefunder, the nation's leading investment crowdfunding platform, today announced a new loan product to help small businesses struggling with the economic impact of coronavirus. The

INDIANAPOLIS, March 24, 2020 /PRNewswire/ -- To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly and Company (NYSE: LLY) today is providing updates related to insulin supply and affordability:As we announced on March 3, Lilly does not currently anticipate short

AVENTURA, Fla., March 24, 2020 /PRNewswire/ -- Regenr8 today announced an exciting new partnership with Physician's Lab of Boca Raton, Florida. This ground-breaking partnership has enabled a first of its kind epigenetic analysis called the Epigenetic Biomarker Profile™ (EBP™) to determine the impa

RICHMOND, Calif., March 24, 2020 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostic company, announced today that it has filed for Emergency Use Authorization (EUA) with the US FDA for its QuantiVirus™ SARS-CoV-2 test and has validated the COVID-19 diagnostic test in its own CLIA certified lab in Richmond, CA to pr